First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) — Financial Flexibility Index
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Financial Flexibility Index of -0.98x as of March 2026. Free cash flow of $-32.54 Million (operating CF $-32.56 Million minus capex $17.00K) represents -1% of total liabilities ($33.11 Million). Check TRAXV tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Financial Flexibility Index (2023–2024)
Historical Financial Flexibility Index trend for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued across 2 annual periods. For the full cash flow conversion analysis, see TRAXV operating cash flow.
Annual Financial Flexibility Index for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
Year-by-year free cash flow to debt coverage for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued. Explore TRAXV operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | $-125.45 Million | $-125.81 Million | $50.30 Million | ▲ +7.3% |
| 2023 | -2.69x | $-92.20 Million | $-93.00 Million | $34.26 Million | — |